Diabetes is a complex disease

A complex disease dependent on self-care with all kinds of factors affecting the blood glucose.

A New Paradigm for Diabetes Care

The insulin was detected a hundred years ago and before 1921, it was exceptional for people with Type 1 diabetes to live more than two years. The insulin is one of the twentieth century’s greatest medical discoveries and is still today the only effective treatment for people with Type 1 diabetes.

During 1980’s genetically engineered preparations appeared on the market that resembled the body’s own insulin with both short- and long-acting varieties. Around this time the first insulin pumps were introduced.

In the late 1990’s and early 2000’s blood glucose monitoring entered the market with CGM-sensors which enabled more self-care for people with type 1 diabetes. Today, with data from the CGM data there is a data and decision overload for the healthcare providers where the patients have to analyze continuous data manually in order to make daily decisions. Complicated data analysis and physiological modeling are issues as well.

Our solution to this data overload is a clinically validated digital service that generates automated analysis, monitoring, identification of root-causes, and treatment recommendations based on machine learning. DDAnalytics see this as a paradigm shift where we use continuous data to provide better care and decision support for both healthcare providers and people with diabetes – enable daily decision. This is diabetes 3.0.  

CGM/FGM

In Sweden, about 50 000 people are living with type 1 diabetes and a majority of whom use CGM/FGM. Globally, 2 million people use CGM/FGM and more than 6 million people live with type 1 diabetes who all depend on insulin treatment to survive. To control the treatment, they need to measure their blood sugar repeatedly per day and incorrect dosages can be directly fatal.

Type 1

Globally, there are 6 million people living with type 1 diabetes. In Sweden, the number is 50 000 people and a majority use CGM/FGM who all depend on insulin treatment for their survival. 

  • Autoimmune disease
  • Loss off endogennous insulin production
  • Affects children, adolescents and adults
  • Solely dependent on exogenous insulin treatment
  • Insulin can be delivered via an insulin pen or pump

Type 2

Globally, there are 460 million people living with type 2 diabetes. Approximately four percent of the Swedish population has type 2 diabetes and among those over the age of 75 at least ten percent have the disease.

  • Life-style related and hereditary disease
  • Insulin resistance is the hallmark of the disease
  • Affects mainly adults but in increasing numbers also children
  • In first hand oral antidiabetic drugs
  • Exogenous insulin treatment in 20-30% of all patients

Acute & Long-term Complications

For both type 1 and type 2 diabetes, the disease includes a number of complications, both acute and long-term.

Acute complications can cause unconsciousness, coma and death. Long-term complications can cause heart disease, cerebrovascular disease, kidney failure, blindness and premature death. 

Our mission is to provide innovative and data driven analysis services that meet the needs of patients and healthcare providers in diabetes. We strive to always empower persons with diabetes and enable healthcare professionals to become even more supportive.